115 / 490
SUNDAY 1 MAY 2016
113
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
16:35 > Outcome and prognosticators in adult patients with medulloblastoma:
a Rare Cancer Network study
B. Atalar (Turkey), M. Ozsahin, J. Call, A. Napieralska, S. Kamer,
V. Salvador, P. Erpolat, L. Negretti, Y.L. Ramstad, C. Onal, S. Akyurek,
G. Ugurluer, B. Baumert, S. Servagi-Vernat, R.C. Miller, E. Ozyar, T. Sio
OC-0347
16:45 > Tumor bed radiosurgery vs. whole brain radiotherapy after surgery of
single brain metastasis
L. Kepka (Poland), D. Tyc-Szczepaniak, K. Bujko, M. Olszyna-Serementa,
W. Michalski, A. Sprawka, B. Trabska-Kluch, K. Komosinska,
E. Wasilewska-Tesluk, B. Czeremszynska
OC-0348
16:55 > Hippocampal dosimetry predicts the change in neurocognitive functions
after whole brain radiotherapy
S.Y. Lin (Taiwan), C.C. Yang, C.C. Chuang, P.C. Pai, P.F. Tsai, D.L. Tsan,
C.K. Tseng
OC-0349
17:05 > Post-radiation neuronal depletion in hippocampus measured by in-vivo
magnetic resonance spectroscopy
P. Pospisil, T. Kazda (Czech Republic), R. Jancalek, P. Slampa
OC-0350
Proffered Papers
BRACHYTHERAPY 4: GYNAE-BREAST
16:15 - 17:15 | ROOM 4
Chair: A. Cerrotta (Italy)
Chair: H. Westerveld (The Netherlands)
16:15 > MRI-guided brachytherapy in cervical cancer: high doses to small bowel
don’t predict late morbidity
C. Petit (France), R. Mazeron, C. Chargari, I. Dumas, P. Maroun,
P. Annede, T. Seisen, C. Haie Meder
OC-0351
16:25 > The high doses employed in brachytherapy of cervical cancer counteract
hypoxia - a modelling study
E. Lindblom (Sweden), A. Dasu, I. Toma-Dasu
OC-0352
16:35 > EBRT and interstitial brachytherapy for recurrent vault carcinomas:
Factors influencing the outcomes
R. Engineer (India), S. Chopra, U. Mahantshetty, A. Maheshwari,
R. Kerkar, R. Phurailatpam, J. Swamidas, S.K. Shrivastava
OC-0353
16:45 > Artificial neural network for bladder dose interfractional variation
prediction in GYN brachytherapy
Z. Siavashpour (Iran), M.R. Aghamiri, R. Jaberi, R. Ghaderi, C. Kirisits
OC-0354